These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23699634)

  • 21. Combination therapy for treatment of osteoporosis: A review.
    Pinkerton JV; Dalkin AC
    Am J Obstet Gynecol; 2007 Dec; 197(6):559-65. PubMed ID: 18060937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2012 Mar; 22(3):315-20. PubMed ID: 22370297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Guidelines for the diagnosis, prevention and treatment of osteoporosis. Italian Osteoporosis, Mineral Metabolism, and Skeletal Diseases Society].
    Società Italiana dell'Osteoporosi, del Metabolismo Minerale e delle Malattie dello Scheletro
    Minerva Endocrinol; 2013 Mar; 38(1 Suppl 1):1-30. PubMed ID: 23539106
    [No Abstract]   [Full Text] [Related]  

  • 24. Early callus formation in human hip fracture treated with internal fixation and teriparatide.
    Yu CT; Wu JK; Chang CC; Chen CL; Wei JC
    J Rheumatol; 2008 Oct; 35(10):2082-3. PubMed ID: 18843769
    [No Abstract]   [Full Text] [Related]  

  • 25. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.
    Chevalier Y; Quek E; Borah B; Gross G; Stewart J; Lang T; Zysset P
    Bone; 2010 Jan; 46(1):41-8. PubMed ID: 19800436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Teriparatide--new value in osteoporosis treatment: treatment guidelines].
    Korsić M; Kastelan D
    Reumatizam; 2006; 53(2):77-81. PubMed ID: 17580560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teriparatide: new indication. During corticosteroid therapy: no fewer clinical fractures. Unnecessarily inconvenient.
    Prescrire Int; 2009 Aug; 18(102):159. PubMed ID: 19743573
    [No Abstract]   [Full Text] [Related]  

  • 28. Is the current anti-osteoporotic therapy paradigm good enough?
    Fisher AA; Davis MW
    J Am Geriatr Soc; 2006 Dec; 54(12):1960-1, author reply 1961-3. PubMed ID: 17198519
    [No Abstract]   [Full Text] [Related]  

  • 29. Denosumab and atypical femur fractures.
    Cating-Cabral MT; Clarke BL
    Maturitas; 2013 Sep; 76(1):1-2. PubMed ID: 23835004
    [No Abstract]   [Full Text] [Related]  

  • 30. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teriparitide update.
    Silverman SL; Nasser K
    Rheum Dis Clin North Am; 2011 Aug; 37(3):471-7, vii. PubMed ID: 22023903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of the quality-of-life under the treatment of severe senile osteoporosis with teriparatide.
    Maugeri D; Russo E; Luca S; Leotta C; Mamazza G; Sorace R; Rizzotto M; Manuele S; Fiore V; Taverna G; Castiglia B; Calitro M
    Arch Gerontol Geriatr; 2009; 49(1):35-8. PubMed ID: 18555544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis.
    Migliore A; Broccoli S; Massafra U; Bizzi E; Frediani B
    Curr Med Res Opin; 2012 Mar; 28(3):467-73. PubMed ID: 22256908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances in the field of osteoporosis].
    Vignot E; Delmas PD
    Rev Prat; 2007 Oct; 57(15):1629-31. PubMed ID: 18080418
    [No Abstract]   [Full Text] [Related]  

  • 35. The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them.
    Gasser JA
    Curr Opin Pharmacol; 2006 Jun; 6(3):313-8. PubMed ID: 16650802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two-year changes in bone mineral density and T scores in patients treated at a pharmacist-run teriparatide clinic.
    Stroup JS; Rivers SM; Abu-Baker AM; Kane MP
    Pharmacotherapy; 2007 Jun; 27(6):779-88. PubMed ID: 17542760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Secondary osteoporosis UPDATE. Treatment of male osteoporosis. Testosterone replacement therapy etc].
    Kawate H; Takayanagi R
    Clin Calcium; 2010 May; 20(5):744-51. PubMed ID: 20445286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect and role of teriparatide in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PINP as an aid for monitoring patients treated with teriparatide.
    Tsujimoto M; Chen P; Miyauchi A; Sowa H; Krege JH
    Bone; 2011 Apr; 48(4):798-803. PubMed ID: 21168536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.